Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2011-05-03
2011-05-03
Gussow, Anne M. (Department: 1643)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C435S007100
Reexamination Certificate
active
07935346
ABSTRACT:
The present invention describes the use of an agent endowed with tumour tropism in combination with another agent with anticancer activity and with an affinity for the first agent for the preparation of a medicament useful for the two-step perioperative therapy of solid tumours. The advantages of the present invention consist in the greater, effective localisation of its anticancer activity, in the reduction of the number of administration steps and in the possibility of reducing the anticancer doses, with a resulting decrease in side effects, but without any loss of efficacy.
REFERENCES:
patent: 4863713 (1989-09-01), Goodwin et al.
patent: 6054122 (2000-04-01), MacPhee et al.
patent: 2001/0006618 (2001-07-01), Goldenberg
patent: 2003/0003051 (2003-01-01), Inverardi et al.
patent: 2003/0228256 (2003-12-01), Inverardi et al.
patent: 2004/0067199 (2004-04-01), Paganelli et al.
patent: 2005/0154275 (2005-07-01), Chinol et al.
patent: 2006/0251579 (2006-11-01), Paganelli et al.
patent: 0 251 494 (1988-01-01), None
patent: 0 496 074 (1992-07-01), None
patent: 9-506594 (1997-06-01), None
patent: 95/15979 (1995-06-01), None
Definition of endow. American Heritage Dictionary, 2006. Houghton Mifflin Co.
Cokgor, et al. Phase I trial results of iodine-131 labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas. Journal of Clinical Oncology, 2000. vol. 18, pp. 3862-3872.
Stendel, R., Scheurer, L., Schlatterer, K., Gminski, R., and Mohler, H. Taurolidine-fibrin-sealant-matrix using spray application for local treatment of brain tumors. Anticancer research, 2004. vol. 24, pp. 631-638.
Rusckowski, Paganelli, Hnatowich, Magnani, Virzi, Fogarasi, Di Leo, Sudati, and Fazio. Imaging osteomyelitis with streptavidin and indium-111 labeled biotin. Journal of Nuclear Medicine, 1996. vol. 37, pp. 1655-1662.
Samuel, Paganelli, Chiesa, Sudati, Calvitto, Melissano, Grossi, and Fazio. Detection of prosthetic vascular graft infection using avidin/indium-111 biotin scintigraphy. Journal of Nuclear Medicine, 1996. vol. 37, pp. 55-61.
International Search Report of PCT/IT2004/000184, mailed Aug. 31, 2004.
Paganelli et al., “Pre-Targeted Locoregional Radioimmunotherapy with 90Y-Biotin in Glioma Patients: Phase I Study and Preliminary Therapeutic Results”, Cancer Biotherapy and Radiopharmaceuticals, vol. 16, No. 3, 2001, pp. 227-235, XP009012633.
Paganelli et al., “Antibody-Guided Three-step Therapy for High Grade Glioma with YTTRIUM-90 Biotin”, European Journal of Nuclear Medicine, vol. 26, No. 4, Apr. 1999, pp. 348-357, XP008019281.
Knox et al., “Phase II Trial of ytttium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer”, Clinical Cancer Research: An Official journal of the American Association for Cancer Research, Feb. 2000, vol. 6, No. 2, Feb. 2000, pp. 406-414, XP002292435.
Boerman et al. “Pretargeted radioimmunotherapy of cancer: Progress step by step”, Journal of Nuclear Medicine, vol. 44, No. 3, Mar. 2003, pp. 400-411, XP002292436.
Chinol et al. “Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity” Bri. J. Cancer 78:189-197 (1998).
Cremonesi et al. “Three-step radioimmunotherapy with Yttrium-90 biotin: Dosimetry and pharmacokinetics in cancer patients” Eur. J. Nuclear Med. 26:110-120 (1999).
Mariani et al. “Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancer” Eur. J. Cancer 34:1156-1162 (1998).
Paganelli et al. “Antibody-guided three-step therapy for high grade glioma with Yttrium-90 biotin” Eur. J. Nucl. Med. 26:348-357 (1999).
Salvadori et al. “Conservative emthods for breast cancer of small size: The experience of the National cancer Institute, Milan (1973-1998)” The Breast 8:311-314 (1999).
Trikha et al. “Monoclonal antibodies as therapeutics in oncology” Curr. Opin. Biotechnol. 13:609-614 (2002).
Veronesi et al. “Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer” N. Engl. J. Med. 347:1227-1232 (2002).
Veronesi et al. “Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast” N. Engl. J. Med. 305:6-11 (1981).
Veronesi et al. “Comparison of halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: Long-term results” Eur. J. Cancer Clin. Oncol. 22:1085-1089 (1986).
Veronesi et al. “Conservative treatment of early breast cancer” Ann. Surg. vol. 211:250-259 (1990).
Veronesi et al. “Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients” Eur. J. of Cancer 31A:1574-1579 (1995).
Veronesi et al. “Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial” Ann. of Oncol. 12:997-1003 (2001).
Paganelli et al. “IART®: Intraoperative avidation for radionuclide treatment. A new way of partial breast irradiation” Breast 16:17-26 (2006).
Paganelli et al. “Intraoperative avidation for radionuclide therapy: A prospective new development to accelerate radiotherapy in breast cancer” Clin. Cancer Res. 13 (18 suppl):5646s-5651s (2007).
Carminati Paolo
Paganelli Giovanni
Veronesi Umberto
Gussow Anne M.
Lucas & Mercanti LLP
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
LandOfFree
Medicament for the two-step perioperative therapy of solid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicament for the two-step perioperative therapy of solid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament for the two-step perioperative therapy of solid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2620056